Illumina Announces Participation in 2025 Investor Conference
Illumina, Inc. (NASDAQ: ILMN), a leader in DNA sequencing and genomics innovation, has revealed that its executives will take part in an important upcoming investor conference. This news showcases the company’s commitment to engaging with investors and the broader community regarding their advancements and future directions.
Details of the Conference
The conference named the Wolfe Research Healthcare Conference is set to take place soon. Illumina’s fireside chat is scheduled for 6:20 AM Pacific Time, which is equivalent to 9:20 AM Eastern Time. This format offers a unique opportunity for dialogue, giving investors insights into the company’s strategic vision and performance.
Accessing the Webcast
For those interested in following Illumina's insights during the conference, a webcast will be available through the Investor Info section of Illumina's official website. This allows participants, both present and remote, to tune into the latest updates and discussions directly from the company's executives. After the live session, a replay will also be available for at least 30 days, ensuring no interested party misses out on this vital information.
About Illumina
Illumina is at the forefront of advancing human health by leveraging the power of genomic science. With an unwavering focus on innovation, the company is recognized globally in DNA sequencing and array-based technologies. Illumina serves a diverse customer base across various sectors, including research, clinical, and applied markets. Their versatile products cater to numerous applications in life sciences, oncology, reproductive health, agriculture, and other significant, emerging fields.
Connecting with Illumina
To learn more about Illumina and its contributions to the field of genomics, interested parties can visit their website. The company also encourages engagement through various social media platforms such as X, Facebook, LinkedIn, Instagram, TikTok, and YouTube. These channels provide updates on the latest breakthroughs, products, and corporate news.
Investor Relations Contact
Investors:
Conor McNamara
Phone: +1.858.291.6421
Email: [email protected]
Media:
Christine Douglass
Email: [email protected]
Frequently Asked Questions
What is the purpose of the Wolfe Research Healthcare Conference?
The Wolfe Research Healthcare Conference aims to connect healthcare leaders with investors, providing insights into industry developments and company strategies.
How can I access the Illumina webcast?
You can access the Illumina webcast through the Investor Info section of their official website, where it will also be archived for later viewing.
What innovations is Illumina currently focused on?
Illumina is focused on advancing genome sequencing technologies and expanding applications in various fields, including oncology and reproductive health.
Who can I contact for investor inquiries about Illumina?
For investor inquiries, you can contact Conor McNamara at +1.858.291.6421.
Where can I find more information about Illumina?
More information about Illumina's products, innovations, and news can be found on their official website and social media platforms.